Angelo Antonini, May 2020 – Neurological and Psychiatric Events in Patients with COVID-19
Access all of the content
We caught up with our Editorial Board member, Angelo Antonini (University of Padova, Veneto, Italy), to discuss the neurological and psychiatric events that have been observed in patients with COVID-19, what could be done to prepare for these and if anything can be learnt from current experience.
1. Could you tell us about the neurologic and psychiatric events that have been experienced by some patients with COVID-19? (0:05)
2. Do we know how the virus could be affecting the central nervous system and peripheral nervous system? (1:46)
3. How can neurologists prepare themselves for these complications? (3:31)
4. Could neurologists learn anything else from your experiences? (4:57)
Speaker disclosure: Angelo Antonini has received honoraria for consultancies, advisory boards and/or speaker activities from: AbbVie, Bial, Boehringer Ingelheim, General Electric, NeuroDerm, UCB and Zambon. He has received research support from: Chiesi, Lundbeck, AbbVie, Horizon 2020 and MIUR.
Support: Interview and filming supported by Touch Medical Media.
Filmed, May 2020.
Share this Video
Related Videos In COVID-19
Suman Kushwaha, MDS 2022: COVID-19 vaccine induced parkinsonism and cognitive dysfunction
Two cases of COVID-19 vaccination associated neurological symptoms were presented, with patients displaying parkinsonism and cognitive dysfunction. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behaviour and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms and investigations leading to the case report conclusions. The abstract entitled […]
Suman Kushwaha, MDS 2022: Neurological symptoms and COVID-19 vaccination
Neurological complications, such as peripheral neuropathy, have been associated with COVID-19 vaccination. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behavior and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms that have been observed. The abstract entitled ‘Covid vaccine induced parkinsonism and cognitive dysfunction’ was presented […]
Raquel Gil-Gouveia, EAN 2022: Highlights in headache and migraine – Treatment advances, strategies for prevention, Anti-CGRP use in migraine, COVID-19
Headache is one of the most common nervous system disorders. In an interview with touchNEUROLOGY, Dr Raquel Gil-Gouveia (Hospital da Luz, Lisbon, Portugal) summarizes the ePoster session she chaired at EAN 2022, ranging from topics such as how COVID-19 has impacted on young people with headaches, the potential of new treatments such as eptinezumab and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!